Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors and anticancer agents. Its structure supports the creation of targeted therapies by enabling selective binding to enzyme active sites. Also employed in research for developing new fluorinated quinoline derivatives with potential antimicrobial and anti-inflammatory properties. Commonly utilized in medicinal chemistry for structure-activity relationship (SAR) studies due to the presence of reactive halogen groups that allow further functionalization.